| Name | Title | Contact Details |
|---|---|---|
Misti Gault |
Laboratory Director | Profile |
Mary Blackburn |
VP for Growth and Market Development | Profile |
We are dedicated to creating affordable, accessible, and accurate eye care solutions specifically for you and your family. Our founders bring patents from MIT and decades of eye care industry experience to create innovative eye care products that can be used in our every day lives. The traditional eye care system hasnt changed in decades, but our advanced optical technology combined with the modern capabilities of smartphones, have shaped a new avenue of health technology - at home vision testing.
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).
Steadfast Data Systems is a Evanston, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
A remote care platform to impact patients at scale